City of Jenks v. Purdue Pharma L.P. et al
Consolidated
Lead case: 1:17-md-02804
Lead case: 1:17-md-02804
| Ohio Northern District Court | |
| Judge: | Dan Aaron Polster |
| Case #: | 1:19-op-45858 |
| Nature of Suit | 360 Torts - Personal Injury - Other Personal Injury |
| Cause | MDL2804 |
| Case Filed: | Oct 18, 2019 |
| Case in other court: | Oklahoma Northern, 4:19-cv-00380 |
| Last checked: Friday Nov 08, 2019 8:30 PM EST |
|
Defendant
Purdue Frederick Company, Inc., The
|
Represented By
|
|
Defendant
Johnson & Johnson
|
Represented By
|
|
Defendant
Keysource Medical, Inc.
|
|
|
Defendant
Mallinckrodt LLC
|
|
|
Defendant
Mallinckrodt PLC
|
|
|
Defendant
McKesson Corp.
|
Represented By
|
|
Defendant
Morris & Dickson Co LLC
|
|
|
Defendant
Oklahoma CVS Pharmacy, LLC
|
Represented By
|
|
Defendant
Ortho-McNeil-Janssen Pharmaceuticals, Inc.
|
Represented By
|
|
Defendant
Physicians Total Care Inc
|
|
|
Defendant
Janssen Pharmaceuticals Inc.
|
Represented By
|
|
Defendant
Purdue Pharma Inc.
|
Represented By
|
|
Defendant
Purdue Pharma L.P.
|
Represented By
|
|
Defendant
Quest Pharmaceuticals, Inc.
|
Represented By
|
|
Defendant
Teva Pharmaceutical Industries Ltd.
|
|
|
Defendant
Teva Pharmaceuticals USA, Inc.
|
Represented By
|
|
Defendant
Walgreens Boots Alliance Inc.
|
Represented By
|
|
Defendant
Watson Laboratories Inc.
|
Represented By
|
|
Defendant
Watson Pharma, Inc.
|
|
|
Defendant
Watson Pharmaceuticals, Inc.
|
Represented By
|
|
Defendant
Cardinal Health Inc.
|
Represented By
|
|
Defendant
Actavis LLC
|
Represented By
|
|
Defendant
Actavis Pharma, Inc.
|
Represented By
|
|
Defendant
Activas PLC
|
|
|
Defendant
Allergan PLC
|
|
|
Defendant
AmerisourceBergen Drug Corporation
|
Represented By
|
|
Defendant
Anda Inc
|
Represented By
|
|
Defendant
Anda Pharmaceuticals, Inc.
|
Represented By
|
|
Defendant
CVS Health Corporation
|
Represented By
|
|
Defendant
CVS Pharmacy Inc.
|
Represented By
|
|
Defendant
Cephalon Inc.
|
Represented By
|
|
Defendant
Endo Health Solutions Inc.
|
Represented By
|
|
Defendant
Endo Pharmaceuticals Inc.
|
Represented By
|
|
Defendant
GCP Pharma LLC
|
|
|
Defendant
Harvard Drug Company, LLC
|
Represented By
|
|
Defendant
Insys Therapeutics, Inc.
|
|
|
Defendant
Janssen Phamaceutica, Inc.
|
Represented By
|
|
Plaintiff
City of Jenks
|
Represented By
|
| Docket last updated: 10/21/2019 9:32 AM EDT |
| Friday, June 14, 2019 | ||
| PETITION/COMPLAINT with Jury Demand filed in State Court against All Defendants by City of Jenks (jln, Dpty Clk) [Transferred from oknd on 10/18/2019.] | ||
| Thursday, July 11, 2019 | ||
| 1 | 1
CIVIL COVER SHEET by Endo Health Solutions Inc., Endo Pharmaceuticals Inc. (Zschiesche, Raymond) [Transferred from oknd on 10/18/2019.]
|
|
| 2 | 2
NOTICE of Removal from District Court of Tulsa County, Oklahoma, case number CJ-2019-02431 (paid $400 filing fee; receipt number 1085-2077419) by Endo Health Solutions Inc., Endo Pharmaceuticals Inc. (With attachments) (Zschiesche, Raymond) [Transferred from oknd on 10/18/2019.]
|
|
| 3 | 3
ATTORNEY APPEARANCE by Raymond Edward Zschiesche on behalf of Endo Health Solutions Inc., Endo Pharmaceuticals Inc. (Zschiesche, Raymond) [Transferred from oknd on 10/18/2019.]
|
|
| 4 | 4
CORPORATE DISCLOSURE STATEMENT (identifying: Corporate Parent Endo International plc for Endo Pharmaceuticals Inc.) by Endo Health Solutions Inc., Endo Pharmaceuticals Inc. (Zschiesche, Raymond) [Transferred from oknd on 10/18/2019.]
|
|
| 5 | 5
CORPORATE DISCLOSURE STATEMENT (identifying: Corporate Parent Endo International plc for Endo Health Solutions Inc.) by Endo Health Solutions Inc., Endo Pharmaceuticals Inc. (Zschiesche, Raymond) [Transferred from oknd on 10/18/2019.]
|
|
| 6 | 6 MINUTE ORDER by Court Clerk , directing Endo Health Solutions Inc., Endo Pharmaceuticals Inc., McKesson Corp., Cardinal Health, Inc., AmerisourceBergen Corp. and Harvard Drug Group, LLC, The to file a Corporate Disclosure Statement pursuant to FRCvP 7.1 within seven (7) days of this order, if they have not already done so. The parties shall use the form entitled Corporate Disclosure Statement available on the Courts website (please do not refile if already filed on non-court form unless directed to do so). If you have already filed your Corporate Disclosure Statement in this case, you are reminded to file a Supplemental Corporate Disclosure Statement within a reasonable time of any change in the information that the statement requires. (This entry is the Official Order of the Court. No document is attached.) (jln, Dpty Clk) [Transferred from oknd on 10/18/2019.] | |
| 7 | 7 MINUTE ORDER by Court clerk randomly reassigning case due to attorney conflict , recusing Chief Judge John E Dowdell. Judge Gregory K Frizzell reassigned to case., changing case number to 19-CV-380-GKF-FHM (This entry is the Official Order of the Court. No document is attached.) (lml, Dpty Clk) [Transferred from oknd on 10/18/2019.] | |
| 8 | 8
STATUS REPORT on Removed Action by Endo Health Solutions Inc., Endo Pharmaceuticals Inc. (Zschiesche, Raymond) [Transferred from oknd on 10/18/2019.]
|
|
| Friday, July 12, 2019 | ||
| 9 | 9
ATTORNEY APPEARANCE by Susan E Huntsman on behalf of AmerisourceBergen Drug Corporation (Huntsman, Susan) [Transferred from oknd on 10/18/2019.]
|
|
| 10 | 10
CORPORATE DISCLOSURE STATEMENT (identifying: Corporate Parent AmerisourceBergen Corporation, Corporate Parent AmerisourceBergen Services Corporation for AmerisourceBergen Drug Corporation) by AmerisourceBergen Drug Corporation (Huntsman, Susan) [Transferred from oknd on 10/18/2019.]
|
|
| 11 | 11
ATTORNEY APPEARANCE by D Michael McBride, III on behalf of AmerisourceBergen Drug Corporation (McBride, D) [Transferred from oknd on 10/18/2019.]
|
|
| 12 | 12
ATTORNEY APPEARANCE by Ryan A Ray on behalf of Cardinal Health, Inc. (Ray, Ryan) [Transferred from oknd on 10/18/2019.]
|
|
| 13 | 13
ATTORNEY APPEARANCE by Ryan A Ray on behalf of Harvard Drug Group, LLC, The (Ray, Ryan) [Transferred from oknd on 10/18/2019.]
|
|
| 14 | 14
CORPORATE DISCLOSURE STATEMENT by Cardinal Health, Inc. (Ray, Ryan) [Transferred from oknd on 10/18/2019.]
|
|
| 15 | 15
CORPORATE DISCLOSURE STATEMENT (identifying: Corporate Parent Cardinal Health, Inc., Corporate Parent Generic Drug Holdings, Inc., Corporate Parent HDG Acquisition, Inc., Corporate Parent Cardinal Health 110, LLC for Harvard Drug Group, LLC, The) by Harvard Drug Group, LLC, The (Ray, Ryan) [Transferred from oknd on 10/18/2019.]
|
|
| Monday, July 15, 2019 | ||
| 16 | 16
ATTORNEY APPEARANCE by Ashley E Quinn on behalf of Anda Pharmaceuticals, Inc., Anda, Inc. [Note: Attorney Ashley E Quinn added to party Anda Pharmaceuticals, Inc.(pty:dft), Attorney Ashley E Quinn added to party Anda, Inc.(pty:dft).] (Quinn, Ashley) [Transferred from oknd on 10/18/2019.]
|
|
| 17 | 17
CORPORATE DISCLOSURE STATEMENT (identifying: Corporate Parent TEVA Pharmaceuticals Industries, LTD for Anda Pharmaceuticals, Inc., Anda, Inc.) by Anda Pharmaceuticals, Inc., Anda, Inc. (Quinn, Ashley) [Transferred from oknd on 10/18/2019.]
|
|
| 18 | 18
Unopposed MOTION for Extension of Time to Answer by Anda Pharmaceuticals, Inc., Anda, Inc. (Quinn, Ashley) [Transferred from oknd on 10/18/2019.]
|
|
| 19 | 19
ATTORNEY APPEARANCE by Jeffrey Allen Curran on behalf of Anda Pharmaceuticals, Inc., Anda, Inc. [Note: Attorney Jeffrey Allen Curran added to party Anda Pharmaceuticals, Inc.(pty:dft), Attorney Jeffrey Allen Curran added to party Anda, Inc.(pty:dft).] (Curran, Jeffrey) [Transferred from oknd on 10/18/2019.]
|
|
| 20 | 20
ATTORNEY APPEARANCE by Stuart Douglas Campbell on behalf of McKesson Corp. (Campbell, Stuart) [Transferred from oknd on 10/18/2019.]
|
|
| 21 | 21
CORPORATE DISCLOSURE STATEMENT by McKesson Corp. (Campbell, Stuart) [Transferred from oknd on 10/18/2019.]
|
|
| Tuesday, July 16, 2019 | ||
| 22 | 22 MINUTE ORDER by Judge Gregory K Frizzell Granting Unopposed Joint Motion to Extend Time to Answer, Move, or Otherwise Respond to Petition Under Rule 12 [Doc. 18]. Anda Defendants shall answer, move, or otherwise respond to Plaintiffs Complaint within forty-five (45) days after the later of an entry of: 1) a decision by the JPML granting a motion to vacate a conditional transfer order covering this action or otherwise finally denying transfer of this action, or 2) this Courts ruling on any motion to remand this action. ; granting18 Motion for Extension of Time to Answer (This entry is the Official Order of the Court. No document is attached.) (kjp, Dpty Clk) [Transferred from oknd on 10/18/2019.] | |
| 23 | 23
Unopposed MOTION for Extension of Time to Answer or File Responsive Pleadings by Watson Pharmaceuticals, Inc. [Note: Attorney William A Johnson added to party Watson Pharmaceuticals, Inc.(pty:dft).] (Johnson, William) [Transferred from oknd on 10/18/2019.]
|
|
| 24 | 24
ORDER by Judge Gregory K Frizzell ; granting23 Motion for Extension of Time to Answer (kjp, Dpty Clk) [Transferred from oknd on 10/18/2019.]
|
|
| 25 | 25
ATTORNEY APPEARANCE by John Hunt Sparks on behalf of Janssen Pharmaceutica, Inc., Janssen Pharmaceuticals, Inc., Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals, Inc. [Note: Attorney John Hunt Sparks added to party Janssen Pharmaceutica, Inc.(pty:dft), Attorney John Hunt Sparks added to party Janssen Pharmaceuticals, Inc.(pty:dft), Attorney John Hunt Sparks added to party Johnson & Johnson(pty:dft), Attorney John Hunt Sparks added to party Ortho-McNeil-Janssen Pharmaceuticals, Inc.(pty:dft).] (Sparks, John) [Transferred from oknd on 10/18/2019.]
|
|
| 26 | 26
ATTORNEY APPEARANCE by Michael W Ridgeway on behalf of Janssen Pharmaceutica, Inc., Janssen Pharmaceuticals, Inc., Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals, Inc. [Note: Attorney Michael W Ridgeway added to party Janssen Pharmaceutica, Inc.(pty:dft), Attorney Michael W Ridgeway added to party Janssen Pharmaceuticals, Inc.(pty:dft), Attorney Michael W Ridgeway added to party Johnson & Johnson(pty:dft), Attorney Michael W Ridgeway added to party Ortho-McNeil-Janssen Pharmaceuticals, Inc.(pty:dft).] (Ridgeway, Michael) [Transferred from oknd on 10/18/2019.]
|
|
| 27 | 27
CORPORATE DISCLOSURE STATEMENT (identifying: Corporate Parent Johnson & Johnson for Janssen Pharmaceutica, Inc., Janssen Pharmaceuticals, Inc., Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals, Inc.) by Janssen Pharmaceutica, Inc., Janssen Pharmaceuticals, Inc., Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals, Inc. (Ridgeway, Michael) [Transferred from oknd on 10/18/2019.]
|
|
| Wednesday, July 17, 2019 | ||
| 28 | 28 MINUTE ORDER by Court Clerk , directing Anda Pharmaceuticals, Inc., Anda, Inc. and McKesson Corp. to file a Corporate Disclosure Statement pursuant to FRCvP 7.1 within seven (7) days of this order, if they have not already done so. The parties shall use the form entitled Corporate Disclosure Statement available on the Courts website (please do not refile if already filed on non-court form unless directed to do so). If you have already filed your Corporate Disclosure Statement in this case, you are reminded to file a Supplemental Corporate Disclosure Statement within a reasonable time of any change in the information that the statement requires. (This entry is the Official Order of the Court. No document is attached.) (jln, Dpty Clk) [Transferred from oknd on 10/18/2019.] | |
| 29 | 29
ATTORNEY APPEARANCE by William A Johnson on behalf of Watson Pharmaceuticals, Inc. (Johnson, William) [Transferred from oknd on 10/18/2019.]
|
|
| 30 | 30
ATTORNEY APPEARANCE by Elizabeth Anne Price on behalf of Watson Pharmaceuticals, Inc. [Note: Attorney Elizabeth Anne Price added to party Watson Pharmaceuticals, Inc.(pty:dft).] (Price, Elizabeth) [Transferred from oknd on 10/18/2019.]
|
|
| 31 | 31
ATTORNEY APPEARANCE by Nicholas Vernon Merkley on behalf of Actavis LLC, Actavis Pharma, Inc., Cephalon, Inc., Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc. [Note: Attorney Nicholas Vernon Merkley added to party Actavis LLC(pty:dft), Attorney Nicholas Vernon Merkley added to party Actavis Pharma, Inc.(pty:dft), Attorney Nicholas Vernon Merkley added to party Cephalon, Inc.(pty:dft), Attorney Nicholas Vernon Merkley added to party Teva Pharmaceuticals USA, Inc.(pty:dft), Attorney Nicholas Vernon Merkley added to party Watson Laboratories, Inc.(pty:dft).] (Merkley, Nicholas) [Transferred from oknd on 10/18/2019.]
|
|
| 32 | 32
CORPORATE DISCLOSURE STATEMENT (identifying: Corporate Parent TEVA Pharmaceuticals Industries, LTD for Actavis LLC, Actavis Pharma, Inc., Cephalon, Inc., Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc.) by Actavis LLC, Actavis Pharma, Inc., Cephalon, Inc., Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc. (Merkley, Nicholas) [Transferred from oknd on 10/18/2019.]
|
|
| Thursday, July 18, 2019 | ||
| 33 | 33 MINUTE ORDER by Court Clerk , directing Janssen Pharmaceuticals, Inc., Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals, Inc., Janssen Pharmaceutica, Inc. and Watson Pharmaceuticals, Inc. to file a Corporate Disclosure Statement pursuant to FRCvP 7.1 within seven (7) days of this order, if they have not already done so. The parties shall use the form entitled Corporate Disclosure Statement available on the Courts website (please do not refile if already filed on non-court form unless directed to do so). If you have already filed your Corporate Disclosure Statement in this case, you are reminded to file a Supplemental Corporate Disclosure Statement within a reasonable time of any change in the information that the statement requires. (This entry is the Official Order of the Court. No document is attached.) (jln, Dpty Clk) [Transferred from oknd on 10/18/2019.] | |
| 34 | 34
ATTORNEY APPEARANCE by Robert Garner McCampbell on behalf of Actavis LLC, Actavis Pharma, Inc., Cephalon, Inc., Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc. [Note: Attorney Robert Garner McCampbell added to party Actavis LLC(pty:dft), Attorney Robert Garner McCampbell added to party Actavis Pharma, Inc.(pty:dft), Attorney Robert Garner McCampbell added to party Cephalon, Inc.(pty:dft), Attorney Robert Garner McCampbell added to party Teva Pharmaceuticals USA, Inc.(pty:dft), Attorney Robert Garner McCampbell added to party Watson Laboratories, Inc.(pty:dft).] (McCampbell, Robert) Modified on 7/19/2019 to remove filers selected in error (sac-qc, Dpty Clk). [Transferred from oknd on 10/18/2019.]
|
|
| Friday, July 19, 2019 | ||
| MINUTE ORDER by Court Clerk , directing Cephalon, Inc., Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc., Actavis Pharma, Inc. and Actavis LLC to file a Corporate Disclosure Statement pursuant to FRCvP 7.1 within seven (7) days of this order, if they have not already done so. The parties shall use the form entitled Corporate Disclosure Statement available on the Courts website (please do not refile if already filed on non-court form unless directed to do so). If you have already filed your Corporate Disclosure Statement in this case, you are reminded to file a Supplemental Corporate Disclosure Statement within a reasonable time of any change in the information that the statement requires. (This entry is the Official Order of the Court. No document is attached.) (jln, Dpty Clk) [Transferred from oknd on 10/18/2019.] | ||
| NOTICE of Docket Entry Modification; Error: filers selected in error; Correction: removed filers selected in error (sac-qc, Dpty Clk) [Transferred from oknd on 10/18/2019.] | ||
| Monday, July 22, 2019 | ||
| 35 | 35
Amended NOTICE of Removal by McKesson Corp. (With attachments) (Campbell, Stuart) Modified on 7/24/2019 to change text to reflect correct event (sac-qc, Dpty Clk). [Transferred from oknd on 10/18/2019.]
|
|
| Wednesday, July 24, 2019 | ||
| NOTICE of Docket Entry Modification; Error: wrong event selected (Notice - Other); Correction: changed text to reflect correct event (Notice of Removal - Amended) (sac-qc, Dpty Clk) [Transferred from oknd on 10/18/2019.] | ||
| Thursday, July 25, 2019 | ||
| 36 | 36
Unopposed MOTION for Extension of Time to Answer Move or Otherwise Respond to Petition Under Rule 12 by AmerisourceBergen Drug Corporation, Cardinal Health, Inc., Harvard Drug Group, LLC, The, McKesson Corp. (Campbell, Stuart) [Transferred from oknd on 10/18/2019.]
|
|
| 37 | 37 MINUTE ORDER by Judge Gregory K Frizzell ; granting36 Motion for Extension of Time to Answer (This entry is the Official Order of the Court. No document is attached.) (lah, Chambers) [Transferred from oknd on 10/18/2019.] | |
| Friday, July 26, 2019 | ||
| 38 | 38
ATTORNEY APPEARANCE by D Todd Riddles on behalf of Quest Pharmaceuticals, Inc. [Note: Attorney D Todd Riddles added to party Quest Pharmaceuticals, Inc.(pty:dft).] (Riddles, D) [Transferred from oknd on 10/18/2019.]
|
|
| 39 | 39
Unopposed MOTION for Extension of Time to Answer , Move or Otherwise Respond to Petition Under Rule 12 by Quest Pharmaceuticals, Inc. (Riddles, D) [Transferred from oknd on 10/18/2019.]
|
|
| 40 | 40
CORPORATE DISCLOSURE STATEMENT (identifying: Corporate Parent Quest Pharmaceuticals, Inc. for Quest Pharmaceuticals, Inc.) by Quest Pharmaceuticals, Inc. (Riddles, D) [Transferred from oknd on 10/18/2019.]
|
|
| 41 | 41
ORDER by Judge Gregory K Frizzell ; granting39 Motion for Extension of Time to Answer (kjp, Dpty Clk) [Transferred from oknd on 10/18/2019.]
|
|
| Tuesday, July 30, 2019 | ||
| 42 | 42 MINUTE ORDER by Court Clerk , directing Quest Pharmaceuticals, Inc. to file a Corporate Disclosure Statement pursuant to FRCvP 7.1 within seven (7) days of this order, if they have not already done so. The parties shall use the form entitled Corporate Disclosure Statement available on the Courts website (please do not refile if already filed on non-court form unless directed to do so). If you have already filed your Corporate Disclosure Statement in this case, you are reminded to file a Supplemental Corporate Disclosure Statement within a reasonable time of any change in the information that the statement requires. (This entry is the Official Order of the Court. No document is attached.) (dlg, Dpty Clk) [Transferred from oknd on 10/18/2019.] | |
| Friday, August 02, 2019 | ||
| 43 | 43
ATTORNEY APPEARANCE by Sanford C Coats on behalf of Purdue Frederick Company, Inc., The, Purdue Pharma Inc., Purdue Pharma L.P. [Note: Attorney Sanford C Coats added to party Purdue Frederick Company, Inc., The(pty:dft), Attorney Sanford C Coats added to party Purdue Pharma Inc.(pty:dft), Attorney Sanford C Coats added to party Purdue Pharma L.P.(pty:dft).] (Coats, Sanford) [Transferred from oknd on 10/18/2019.]
|
|
| 44 | 44
Unopposed MOTION for Extension of Time to Answer Move or Otherwise Respond to Petition Under Rule 12 by CVS Health Corporation, CVS Pharmacy, Inc., Oklahoma CVS Pharmacy, LLC, Walgreens Boots Alliance, Inc. [Note: Attorney G Calvin Sharpe added to party CVS Health Corporation(pty:dft), Attorney G Calvin Sharpe added to party CVS Pharmacy, Inc.(pty:dft), Attorney G Calvin Sharpe added to party Oklahoma CVS Pharmacy, LLC(pty:dft), Attorney G Calvin Sharpe added to party Walgreens Boots Alliance, Inc.(pty:dft).] (Sharpe, G) [Transferred from oknd on 10/18/2019.]
|
|
| 45 | 45
ORDER by Judge Gregory K Frizzell ; granting44 Motion for Extension of Time to Answer (kjp, Dpty Clk) [Transferred from oknd on 10/18/2019.]
|
|
| Monday, August 05, 2019 | ||
| 46 | 46
CORPORATE DISCLOSURE STATEMENT (identifying: Other Affiliate Purdue Pharma Inc., Other Affiliate Pharmaceutical Research Associates L.P. for Purdue Pharma L.P.) by Purdue Pharma L.P. (Coats, Sanford) [Transferred from oknd on 10/18/2019.]
|
|
| 47 | 47
CORPORATE DISCLOSURE STATEMENT by Purdue Pharma Inc. (Coats, Sanford) [Transferred from oknd on 10/18/2019.]
|
|
| 48 | 48
CORPORATE DISCLOSURE STATEMENT (identifying: Corporate Parent Pharmaceutical Research Associates, Inc. for Purdue Frederick Company, Inc., The) by Purdue Frederick Company, Inc., The (Coats, Sanford) [Transferred from oknd on 10/18/2019.]
|
|
| Tuesday, August 06, 2019 | ||
| 49 | 49 MINUTE ORDER by Court Clerk , directing Purdue Pharma L.P, Purdue Pharma Inc., Purdue Frederick Company, Inc., The, CVS Health Corporation, CVS Pharmacy, Inc. and Oklahoma CVS Pharmacy, LLC to file a Corporate Disclosure Statement pursuant to FRCvP 7.1 within seven (7) days of this order, if they have not already done so. The parties shall use the form entitled Corporate Disclosure Statement available on the Courts website (please do not refile if already filed on non-court form unless directed to do so). If you have already filed your Corporate Disclosure Statement in this case, you are reminded to file a Supplemental Corporate Disclosure Statement within a reasonable time of any change in the information that the statement requires. (This entry is the Official Order of the Court. No document is attached.) (jln, Dpty Clk) [Transferred from oknd on 10/18/2019.] | |
| Friday, August 09, 2019 | ||
| 50 | 50
MOTION to Remand and Brief in Support by City of Jenks (With attachments) (kjp, Dpty Clk) [Transferred from oknd on 10/18/2019.]
|
|
| 51 | 51
MOTION to Expedite Ruling - Plaintiff's Motion for Expedited Treatment of Motion to Remand by City of Jenks (With attachments) (kjp, Dpty Clk) [Transferred from oknd on 10/18/2019.]
|
|
| Tuesday, August 13, 2019 | ||
| 52 | 52
CORPORATE DISCLOSURE STATEMENT by CVS Health Corporation (Sharpe, G) [Transferred from oknd on 10/18/2019.]
|
|
| 53 | 53
CORPORATE DISCLOSURE STATEMENT (identifying: Corporate Parent CVS Health Corporation for CVS Pharmacy, Inc.) by CVS Pharmacy, Inc. (Sharpe, G) [Transferred from oknd on 10/18/2019.]
|
|
| 54 | 54
CORPORATE DISCLOSURE STATEMENT (identifying: Corporate Parent CVS Pharmacy, Inc. for Oklahoma CVS Pharmacy, LLC) by Oklahoma CVS Pharmacy, LLC (Sharpe, G) [Transferred from oknd on 10/18/2019.]
|
|
| Friday, August 16, 2019 | ||
| 55 | 55
Joint MOTION to Stay Proceedings Pending Likely Transfer to Multidistrict Litigation by McKesson Corp. (Campbell, Stuart) [Transferred from oknd on 10/18/2019.]
|
|
| 56 | 56
RESPONSE in Opposition to Motion by McKesson Corp. ; (Campbell, Stuart) [Transferred from oknd on 10/18/2019.]
|
|
| Monday, August 19, 2019 | ||
| 57 | 57 MINUTE ORDER by Judge Gregory K Frizzell Response deadline to the Joint Motion to Stay Proceedings [Doc. 55] is due by August 26, 2019. A Reply, limited to 5 pages, is due by August 28, 2019. , setting/resetting deadline(s)/hearing(s): ( Responses due by 8/26/2019, Replies due by 8/28/2019) (This entry is the Official Order of the Court. No document is attached.) (kjp, Dpty Clk) [Transferred from oknd on 10/18/2019.] | |
| Friday, August 23, 2019 | ||
| 58 | 58
RESPONSE in Opposition to Motion by City of Jenks ; (With attachments) (Court, Todd) [Transferred from oknd on 10/18/2019.]
|
|
| Wednesday, August 28, 2019 | ||
| 59 | 59
Joint REPLY to Response to Motion by AmerisourceBergen Drug Corporation, Cardinal Health, Inc., McKesson Corp. ; (Campbell, Stuart) Modified on 8/29/2019 to change text to reflect correct event (sac, Dpty Clk). [Transferred from oknd on 10/18/2019.]
|
|
| Thursday, August 29, 2019 | ||
| 60 | 60
ORDER by Judge Gregory K Frizzell ; staying case; granting55 Motion to Stay (kjp, Dpty Clk) [Transferred from oknd on 10/18/2019.]
|
|
| Friday, August 30, 2019 | ||
| 61 | 61
RESPONSE in Opposition to Motion by Endo Health Solutions Inc., Endo Pharmaceuticals Inc. ; (Zschiesche, Raymond) [Transferred from oknd on 10/18/2019.]
|
|
| 62 | 62
RESPONSE in Opposition to Motion by McKesson Corp. ; (With attachments) (Campbell, Stuart) [Transferred from oknd on 10/18/2019.]
|
|
| Tuesday, September 17, 2019 | ||
| 63 | 63
ATTORNEY APPEARANCE by Joshua D Burns on behalf of Purdue Frederick Company, Inc., The, Purdue Pharma Inc., Purdue Pharma L.P. [Note: Attorney Joshua D Burns added to party Purdue Frederick Company, Inc., The(pty:dft), Attorney Joshua D Burns added to party Purdue Pharma Inc.(pty:dft), Attorney Joshua D Burns added to party Purdue Pharma L.P.(pty:dft).] (Burns, Joshua) [Transferred from oknd on 10/18/2019.]
|
|
| 64 | 64
NOTICE of Filing Bankruptcy by Purdue Pharma Inc., Purdue Pharma L.P. (With attachments) (Burns, Joshua) [Transferred from oknd on 10/18/2019.]
|
|
| 65 | 65
ATTORNEY APPEARANCE by Evan Hans Way on behalf of Purdue Frederick Company, Inc., The, Purdue Pharma Inc., Purdue Pharma L.P. [Note: Attorney Evan Hans Way added to party Purdue Frederick Company, Inc., The(pty:dft), Attorney Evan Hans Way added to party Purdue Pharma Inc.(pty:dft), Attorney Evan Hans Way added to party Purdue Pharma L.P.(pty:dft).] (Way, Evan) [Transferred from oknd on 10/18/2019.]
|
|
| Wednesday, September 25, 2019 | ||
| 66 | 66
MOTION to Withdraw Attorney(s) Sanford C. Coats by Purdue Frederick Company, Inc., The, Purdue Pharma Inc., Purdue Pharma L.P. (Coats, Sanford) [Transferred from oknd on 10/18/2019.]
|
|
| 67 | 67
ORDER by Judge Gregory K Frizzell ; terminating attorney Sanford C Coats ; granting66 Motion to Withdraw Attorney(s) (lah, Chambers) [Transferred from oknd on 10/18/2019.]
|
|
| Wednesday, October 02, 2019 | ||
| ***Civil Case Terminated (see document number70 ) (sac, Dpty Clk) [Transferred from oknd on 10/18/2019.] | ||
| 68 | 68
***Remark: Received Transfer Order from MDL re: Transfer (sc, Dpty Clk) (Main Document 68 replaced on 10/2/2019 to attach certified copy) (sc, Dpty Clk). [Transferred from oknd on 10/18/2019.]
|
|
| 69 | 69
MINUTE ORDER from MDL re: transferee clerk to transmit a certified copy of the Panel Order to transfer to the district court from which the action is being transferred (sc, Dpty Clk) [Transferred from oknd on 10/18/2019.]
|
|
| 70 | 70
ORDER by John W. Nichols, Clerk of the MDL Panel , transferring case (terminates case) (Documents Terminated:50 MOTION to Remand and Brief in Support ,51 MOTION to Expedite Ruling - Plaintiff's Motion for Expedited Treatment of Motion to Remand ) (sc, Dpty Clk) (Main Document 70 replaced on 10/3/2019: to attach correct PDF) (sc, Dpty Clk). [Transferred from oknd on 10/18/2019.]
|
|
| Thursday, October 03, 2019 | ||
| 71 | 71
NOTICE of Docket Entry Modification; Error: wrong PDF attached; Correction: attached correct PDF (sc, Dpty Clk) [Transferred from oknd on 10/18/2019.]
|
|
| Friday, October 18, 2019 | ||
| 72 | 72
CASE TRANSFERRED IN from District of Oklahoma Northern. Case number 4:19-cv-00380. Original file, certified copy of transfer order and docket sheet received.
|
|